As financial executives seek to comply with the latest Financial Accounting Standards Board (FASB) pronouncements in the era of Sarbanes-Oxley, companies can no longer look to their accountants to perform non-audit valuation services. As a result, public and private companies are turning to independent firms, such as Applied Economics, to assist with their valuation needs.
Expertise
We are regularly engaged by public companies, privately-held businesses, and the Southeast’s leading CPA firms to provide valuation services for financial reporting purposes. Our tax and financial reporting valuation services include fair value and fair market value opinions used for financial and regulatory reporting. Financial reporting related valuation services include:
- Intangible asset valuations for purchase price allocations (FAS 141 Business Combinations )
- Goodwill and intangible impairment tests (FAS 142 Goodwill and Other Intangible Assets)
- Stock option valuation (FAS 123R Share-Based Payment )
- Derivate valuation (FAS 150 Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity )
Our Team
Founded by former “Big Four” public accounting firm valuation experts, Applied Economics performs over 200 engagements annually, including transfer pricing and financial valuation projects for public and private companies. Our reports have been reviewed and accepted by each of the “Big Four” firms, as well as the Securities and Exchange Commission, the IRS and the Tax Courts.
In addition, we are regularly engaged to perform valuation and transfer pricing engagements by public accounting firms on behalf of their clients due to independence conflicts.
Examples of our recent financial reporting valuation engagements include:
- Valued tradenames, customer relationships and other intangibles of a $103 million national payday loan operator purchased by a publicly traded company a for purchase price allocation purposes.
- Valued healthcare related intangibles of a $450 million home health care provider and hospice operator purchased by a public company for purchase price allocation purposes.
- Valued the internally developed software, customer relationships, and other intangibles of a $100 million printing and information logistics provider for purchase price allocation purposes.
- Valued a $90 million document management solutions provider for annual goodwill impairment testing pursuant to FAS 142.
- Valued a $160 million medical claims processor for annual goodwill impairment testing pursuant to FAS 142.
- Valued employee stock options to assist a national telecom billing provider in its adoption of FAS 123(R).
- Valued put options and other contingent options for SEC compliance purposes in conjunction with a client’s successful registration for initial public offering of stock.
